Unconventional estrogens: Estriol, biest, and triest

Clinical Obstetrics and Gynecology

Volumn 44, Issue 4, 2001, Pages 864-879

  Taylor, Maida ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO MENORETTE; ESTRADIOL; ESTRIOL; ESTRIOL SUCCINATE; ESTROFEM; ESTROFEM FORTE; HORMONIN; MENOFLUSH; ORTHO GYNEST D; SYNAPAUSE FORTE; TRISEQUENS;

BREAST CANCER; CANCER PREVENTION; CREAM; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ENDOMETRIUM CANCER; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; REVIEW; SIDE EFFECT; TREATMENT INDICATION; VAGINA PESSARY;

BREAST; ENDOMETRIUM; ESTRIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; NEOPLASMS; RISK FACTORS; SAFETY;

EID: 0035194342     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200112000-00024     Document Type: Review

References (47)

1. Estrogen replacement therapy and fractures in older women. Study of osteoporotic
2. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
3. Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
4. Patient noncompliance with hormone replacement therapy: A nationwide estimate using a large prescription claims database
5. Risk factors associated with women's compliance with estrogen replacement therapy
6. Estrogens and progestins: What to use and how to use it
7. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group
8. Hormone replacement therapy and risk of hip fracture: Population based casecontrol study
9. Estrogen profiles of Oriental and Caucasian women in Hawaii
10. Case-control study of endogenous steroid hormones and endometrial cancer
11. A prospective study of urinary oestrogen excretion and breast cancer risk
12. Estriol prevention of mammary carcinoma induced by 7,12-dimethylbenzanthracene and procarbazine
13. Pathophysiologic considerations in the treatment of menopausal patients with oestrogens; the role of oestriol in the prevention of mammary carcinoma
14. Diethylstilbestrol: Recommended dosages for different categories of breast cancer patients. Report of the Cooperative Breast Cancer Group
15. Comparison of DES vs DES + chlorambucil in women with first recurrence of breast cancer
16. Estriol: The forgotten estrogen?
17. Oral estrogen replacement
18. Comparison of the ligand binding specificity and transcript distribution of estrogen receptors a and b
19. Biochemical and histological effects of vaginal estriol and estradiol applications on the endometrium, myometrium and vagina of postmenopausal women
20. Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol
21. Uptake and metabolism of oestriol in human target tissues
22. Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiol
23. Prevention of endometrial abnormalities
24. Endometrial effect of oral estriol treatment in postmenopausal women
25. Oestriol with oestradiol veses Oestradiol alone: A comparison of endometrial, symptomatic and psychological effects
26. Hormone replacement regimens and bleeding
27. Review of the endometrial safety during intravaginal treatment with estriol
28. Low-potency oestrogen and risk of endometrial cancer: A case-control study
29. Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture
30. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells
31. Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells
32. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms
33. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy
34. Longterm effects of continuous combined HRT on bone turnover and lipid metabolism in postmenopausal women
35. Efficacy and safety of estriol replacement therapy for climacteric women
36. Efficacy and safety of oral estriol for managing postmenopausal symptoms
37. Effect of estriol on bone loss in postmenopausal Japanese women: A multicenter prospective open study
38. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen, 1-alpha-hydroxyvitamin D3 and calcium lactate on vertebral bone loss in early menopausal women
39. The long-term effects of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterectomized women
40. Bone loss in elderly women prevented by ultralow doses of parenteral 17 beta-estradiol
41. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen on serum lipid profile in early menopausal women
42. Estriol: Safety and efficacy